パーキンソン病環境毒素曝露ヒト神経モデルにおけるクロマチンアクセス可能性とトランスクリプトーム
Jingchao Hong1,2,3, Juanjuan Huang4
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Scientific data
|February 4, 2026
まとめ
ロテノンなどの環境毒性物質は、遺伝子発現とクロマチンアクセス可能性を変化させることにより、パーキンソン病(PD)に影響を与えます。この研究は、散発性PDの原因を理解するために、神経モデルにおけるこれらのエピジェネティックな変化をマッピングします。
キーワード:
パーキンソン病環境毒性物質エピジェネティクスクロマチンアクセス可能性トランスクリプトーム神経毒性物質遺伝子発現散発性パーキンソン病神経モデルSH-SY5Y細胞ロテノンMPP+RNAシーケンシングATACシーケンシングエピジェネティックメカニズム転写調節バイオマーカー発見さらに関連する動画
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
25.3K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
2.1K
関連する概念動画
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
